CLYM
Climb Bio, Inc. Common Stock
CLYM
CLYM
23 hedge funds and large institutions have $45.5M invested in Climb Bio, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
5
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BCM
1
BML Capital Management
Zionsville,
Indiana
|
$5.89M |
| 2 |
2
Northern Trust
Chicago,
Illinois
|
$132K |
| 3 |
3
Cerity Partners
New York
|
$37.3K |
| 4 |
4
Renaissance Technologies
New York
|
$29K |
| 5 |
5
Morgan Stanley
New York
|
$9.23K |
